vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Donnelley Financial Solutions, Inc. (DFIN). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $172.5M, roughly 1.6× Donnelley Financial Solutions, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 3.6%, a 92.7% gap on every dollar of revenue. On growth, Donnelley Financial Solutions, Inc. posted the faster year-over-year revenue change (10.4% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -7.9%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Donnelley Financial Solutions (DFIN) is a financial compliance company based in Chicago, Illinois, United States. The company provides software as a service (SaaS) products, software-enabled services (SeS), print, and compliance services related to US Securities and Exchange Commission regulations to companies in capital and investment markets.
ACAD vs DFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $172.5M |
| Net Profit | $273.6M | $6.2M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 8.3% |
| Net Margin | 96.3% | 3.6% |
| Revenue YoY | 9.4% | 10.4% |
| Net Profit YoY | 90.3% | -1.6% |
| EPS (diluted) | $1.61 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $172.5M | ||
| Q3 25 | $278.6M | $175.3M | ||
| Q2 25 | $264.6M | $218.1M | ||
| Q1 25 | $244.3M | $201.1M | ||
| Q4 24 | $259.6M | $156.3M | ||
| Q3 24 | $250.4M | $179.5M | ||
| Q2 24 | $242.0M | $242.7M | ||
| Q1 24 | $205.8M | $203.4M |
| Q4 25 | $273.6M | $6.2M | ||
| Q3 25 | $71.8M | $-40.9M | ||
| Q2 25 | $26.7M | $36.1M | ||
| Q1 25 | $19.0M | $31.0M | ||
| Q4 24 | $143.7M | $6.3M | ||
| Q3 24 | $32.8M | $8.7M | ||
| Q2 24 | $33.4M | $44.1M | ||
| Q1 24 | $16.6M | $33.3M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 8.3% | ||
| Q3 25 | 12.8% | 16.1% | ||
| Q2 25 | 12.2% | 24.2% | ||
| Q1 25 | 7.9% | 22.8% | ||
| Q4 24 | 59.1% | 6.0% | ||
| Q3 24 | 12.6% | 10.1% | ||
| Q2 24 | 12.6% | 26.6% | ||
| Q1 24 | 7.4% | 21.9% |
| Q4 25 | 96.3% | 3.6% | ||
| Q3 25 | 25.8% | -23.3% | ||
| Q2 25 | 10.1% | 16.6% | ||
| Q1 25 | 7.8% | 15.4% | ||
| Q4 24 | 55.4% | 4.0% | ||
| Q3 24 | 13.1% | 4.8% | ||
| Q2 24 | 13.8% | 18.2% | ||
| Q1 24 | 8.0% | 16.4% |
| Q4 25 | $1.61 | $0.31 | ||
| Q3 25 | $0.42 | $-1.49 | ||
| Q2 25 | $0.16 | $1.28 | ||
| Q1 25 | $0.11 | $1.05 | ||
| Q4 24 | $0.86 | $0.21 | ||
| Q3 24 | $0.20 | $0.29 | ||
| Q2 24 | $0.20 | $1.47 | ||
| Q1 24 | $0.10 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $24.5M |
| Total DebtLower is stronger | — | $171.3M |
| Stockholders' EquityBook value | $1.2B | $379.2M |
| Total Assets | $1.6B | $800.4M |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $24.5M | ||
| Q3 25 | $258.0M | $22.7M | ||
| Q2 25 | $253.6M | $33.8M | ||
| Q1 25 | $217.7M | $16.2M | ||
| Q4 24 | $319.6M | $57.3M | ||
| Q3 24 | $155.1M | $33.6M | ||
| Q2 24 | $177.1M | $35.0M | ||
| Q1 24 | $204.7M | $43.7M |
| Q4 25 | — | $171.3M | ||
| Q3 25 | — | $154.7M | ||
| Q2 25 | — | $190.1M | ||
| Q1 25 | — | $189.5M | ||
| Q4 24 | — | $124.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $379.2M | ||
| Q3 25 | $917.3M | $423.1M | ||
| Q2 25 | $822.4M | $432.1M | ||
| Q1 25 | $765.2M | $419.9M | ||
| Q4 24 | $732.8M | $436.1M | ||
| Q3 24 | $577.2M | $444.5M | ||
| Q2 24 | $516.7M | $441.5M | ||
| Q1 24 | $464.0M | $408.9M |
| Q4 25 | $1.6B | $800.4M | ||
| Q3 25 | $1.3B | $816.3M | ||
| Q2 25 | $1.2B | $874.7M | ||
| Q1 25 | $1.1B | $852.8M | ||
| Q4 24 | $1.2B | $841.6M | ||
| Q3 24 | $976.9M | $843.6M | ||
| Q2 24 | $914.1M | $882.9M | ||
| Q1 24 | $855.1M | $867.8M |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.37× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $59.8M |
| Free Cash FlowOCF − Capex | — | $47.9M |
| FCF MarginFCF / Revenue | — | 27.8% |
| Capex IntensityCapex / Revenue | — | 6.9% |
| Cash ConversionOCF / Net Profit | -0.18× | 9.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $59.8M | ||
| Q3 25 | $74.3M | $74.4M | ||
| Q2 25 | $64.0M | $68.4M | ||
| Q1 25 | $20.3M | $-37.7M | ||
| Q4 24 | $40.4M | $56.4M | ||
| Q3 24 | $63.2M | $86.4M | ||
| Q2 24 | $25.0M | $56.2M | ||
| Q1 24 | $29.1M | $-27.9M |
| Q4 25 | — | $47.9M | ||
| Q3 25 | $73.9M | $59.2M | ||
| Q2 25 | — | $51.7M | ||
| Q1 25 | — | $-51.0M | ||
| Q4 24 | — | $41.3M | ||
| Q3 24 | $63.2M | $67.3M | ||
| Q2 24 | — | $36.8M | ||
| Q1 24 | — | $-40.2M |
| Q4 25 | — | 27.8% | ||
| Q3 25 | 26.5% | 33.8% | ||
| Q2 25 | — | 23.7% | ||
| Q1 25 | — | -25.4% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | 25.2% | 37.5% | ||
| Q2 24 | — | 15.2% | ||
| Q1 24 | — | -19.8% |
| Q4 25 | — | 6.9% | ||
| Q3 25 | 0.1% | 8.7% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | 0.0% | 10.6% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 6.0% |
| Q4 25 | -0.18× | 9.65× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | 1.89× | ||
| Q1 25 | 1.07× | -1.22× | ||
| Q4 24 | 0.28× | 8.95× | ||
| Q3 24 | 1.93× | 9.93× | ||
| Q2 24 | 0.75× | 1.27× | ||
| Q1 24 | 1.76× | -0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
